As of 2025-09-15, the Relative Valuation of Aclaris Therapeutics Inc (ACRS) is (23.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.95 USD, the upside of Aclaris Therapeutics Inc based on Relative Valuation is -1328.6%.
The range of the Relative Valuation is (22.52) - (24.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 19.7x | 18.8x |
| Forward P/E multiples | 18.1x - 21.3x | 19.8x |
| Fair Price | (22.52) - (24.44) | (23.96) |
| Upside | -1255.0% - -1353.2% | -1328.6% |
| Date | P/E |
| 2025-09-12 | -1.57 |
| 2025-09-11 | -1.58 |
| 2025-09-10 | -1.64 |
| 2025-09-09 | -1.71 |
| 2025-09-08 | -1.67 |
| 2025-09-05 | -1.69 |
| 2025-09-04 | -1.67 |
| 2025-09-03 | -1.66 |
| 2025-09-02 | -1.60 |
| 2025-08-29 | -1.55 |
| 2025-08-28 | -1.48 |
| 2025-08-27 | -1.46 |
| 2025-08-26 | -1.46 |
| 2025-08-25 | -1.45 |
| 2025-08-22 | -1.45 |
| 2025-08-21 | -1.41 |
| 2025-08-20 | -1.46 |
| 2025-08-19 | -1.44 |
| 2025-08-18 | -1.49 |
| 2025-08-15 | -1.50 |
| 2025-08-14 | -1.36 |
| 2025-08-13 | -1.37 |
| 2025-08-12 | -1.32 |
| 2025-08-11 | -1.32 |
| 2025-08-08 | -1.31 |
| 2025-08-07 | -1.26 |
| 2025-08-06 | -1.25 |
| 2025-08-05 | -1.25 |
| 2025-08-04 | -1.26 |
| 2025-08-01 | -1.23 |
| 2025-07-31 | -1.23 |
| 2025-07-30 | -1.23 |
| 2025-07-29 | -1.25 |
| 2025-07-28 | -1.35 |
| 2025-07-25 | -1.37 |
| 2025-07-24 | -1.35 |
| 2025-07-23 | -1.35 |
| 2025-07-22 | -1.30 |
| 2025-07-21 | -1.32 |
| 2025-07-18 | -1.30 |
| 2025-07-17 | -1.28 |
| 2025-07-16 | -1.27 |
| 2025-07-15 | -1.22 |
| 2025-07-14 | -1.27 |
| 2025-07-11 | -1.26 |
| 2025-07-10 | -1.28 |
| 2025-07-09 | -1.24 |
| 2025-07-08 | -1.17 |
| 2025-07-07 | -1.17 |
| 2025-07-03 | -1.16 |